NA2 Stock Overview
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Natural Alternatives International, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6.30 |
52 Week High | US$8.05 |
52 Week Low | US$4.92 |
Beta | 0.56 |
1 Month Change | 16.67% |
3 Month Change | 15.60% |
1 Year Change | -18.18% |
3 Year Change | -50.78% |
5 Year Change | -45.86% |
Change since IPO | 10.72% |
Recent News & Updates
Recent updates
Shareholder Returns
NA2 | DE Personal Products | DE Market | |
---|---|---|---|
7D | 5.0% | 4.3% | 0.5% |
1Y | -18.2% | -2.3% | 1.3% |
Return vs Industry: NA2 underperformed the German Personal Products industry which returned -2% over the past year.
Return vs Market: NA2 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
NA2 volatility | |
---|---|
NA2 Average Weekly Movement | 5.7% |
Personal Products Industry Average Movement | 4.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NA2 has not had significant price volatility in the past 3 months.
Volatility Over Time: NA2's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1980 | 317 | Mark LeDoux | www.nai-online.com |
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
Natural Alternatives International, Inc. Fundamentals Summary
NA2 fundamental statistics | |
---|---|
Market cap | €35.76m |
Earnings (TTM) | -€3.83m |
Revenue (TTM) | €119.10m |
0.3x
P/S Ratio-9.3x
P/E RatioIs NA2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NA2 income statement (TTM) | |
---|---|
Revenue | US$127.76m |
Cost of Revenue | US$117.67m |
Gross Profit | US$10.10m |
Other Expenses | US$14.21m |
Earnings | -US$4.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.67 |
Gross Margin | 7.90% |
Net Profit Margin | -3.22% |
Debt/Equity Ratio | 11.0% |
How did NA2 perform over the long term?
See historical performance and comparison